Efficacy of Bamlanivimab/Etesevimab and Casirivimab/Imdevimab in Preventing Progression to Severe COVID-19 and Role of Variants of Concern

被引：0
作者：
Marco Falcone
Giusy Tiseo
Beatrice Valoriani
Chiara Barbieri
Sara Occhineri
Paola Mazzetti
Maria Linda Vatteroni
Lorenzo Roberto Suardi
Niccolò Riccardi
Mauro Pistello
Danilo Tacconi
Francesco Menichetti
机构：
[1] Azienza Ospedaliera Universitaria Pisana,Infectious Diseases Unit, Department of Clinical and Experimental Medicine
[2] University of Pisa,Infectious Disease Unit
[3] San Donato Hospital Arezzo,Virology Unit
[4] Pisa University Hospital,Retrovirus Center, Department of Translational Research
[5] University of Pisa,undefined
来源：
Infectious Diseases and Therapy | 2021年 / 10卷
关键词：
Bamlanivimab/etesevimab; Casirivimab/imdevimab; COVID-19; Monoclonal antibodies; SARS-CoV-2; Variants of concern;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2479 / 2488
页数：9
相关论文
共 50 条
  • [1] Efficacy of Bamlanivimab/Etesevimab and Casirivimab/Imdevimab in Preventing Progression to Severe COVID-19 and Role of Variants of Concern
    Falcone, Marco
    Tiseo, Giusy
    Valoriani, Beatrice
    Barbieri, Chiara
    Occhineri, Sara
    Mazzetti, Paola
    Vatteroni, Maria Linda
    Suardi, Lorenzo Roberto
    Riccardi, Niccolo
    Pistello, Mauro
    Tacconi, Danilo
    Menichetti, Francesco
    INFECTIOUS DISEASES AND THERAPY, 2021, 10 (04) : 2479 - 2488
  • [2] COVID-19: A Review of Potential Treatments (Corticosteroids, Remdesivir, Tocilizumab, Bamlanivimab/Etesevimab, and Casirivimab/Imdevimab) and Pharmacological Considerations
    Nhean, Salin
    Varela, Mario E.
    Nguyen, Y-Nha
    Juarez, Alejandra
    Huynh, Tuyen
    Udeh, Darlington
    Tseng, Alice L.
    JOURNAL OF PHARMACY PRACTICE, 2023, 36 (02) : 407 - 417
  • [3] Emulation of a Target Trial From Observational Data to Compare Effectiveness of Casirivimab/Imdevimab and Bamlanivimab/Etesevimab for Early Treatment of Non-Hospitalized Patients With COVID-19
    Mazzotta, Valentina
    Cozzi-Lepri, Alessandro
    Colavita, Francesca
    Lanini, Simone
    Rosati, Silvia
    Lalle, Eleonora
    Mastrorosa, Ilaria
    Cimaglia, Claudia
    Vergori, Alessandra
    Bevilacqua, Nazario
    Lapa, Daniele
    Mariano, Andrea
    Bettini, Aurora
    Agrati, Chiara
    Piselli, Pierluca
    Girardi, Enrico
    Castilletti, Concetta
    Garbuglia, Anna Rosa
    Vaia, Francesco
    Nicastri, Emanuele
    Antinori, Andrea
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [4] Use of Casirivimab and Imdevimab for the Treatment of COVID-19
    Liu, Ryan
    Mangal, Rohan
    Stead, Thor S.
    Barbera, Andrew R.
    Ganti, Latha
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (08)
  • [5] Treatment of COVID-19 with monoclonal antibodies casirivimab and imdevimab in pregnancy
    Folkman, Rebecca
    Blennow, Ola
    Tovatt, Tuulikki
    Pettersson, Karin
    Nowak, Piotr
    INFECTION, 2023, 51 (01) : 261 - 263
  • [6] Effectiveness of Subcutaneous Casirivimab and Imdevimab in Ambulatory Patients with COVID-19
    Jalbert, Jessica J.
    Hussein, Mohamed
    Mastey, Vera
    Sanchez, Robert J.
    Wang, Degang
    Murdock, Dana
    Farinas, Laura
    Bussey, Jonathan
    Duart, Carlos
    Hirshberg, Boaz
    Weinreich, David M.
    Wei, Wenhui
    INFECTIOUS DISEASES AND THERAPY, 2022, 11 (06) : 2125 - 2139
  • [7] Casirivimab and Imdevimab for the Treatment of Hospitalized Patients With COVID-19
    Somersan-Karakaya, Selin
    Mylonakis, Eleftherios
    Menon, Vidya P.
    Wells, Jason C.
    Ali, Shazia
    Sivapalasingam, Sumathi
    Sun, Yiping
    Bhore, Rafia
    Mei, Jingning
    Miller, Jutta
    Cupelli, Lisa
    Forleo-Neto, Eduardo
    Hooper, Andrea T.
    Hamilton, Jennifer D.
    Pan, Cynthia
    Pham, Viet
    Zhao, Yuming
    Hosain, Romana
    Mahmood, Adnan
    Davis, John D.
    Turner, Kenneth C.
    Kim, Yunji
    Cook, Amanda
    Kowal, Bari
    Soo, Yuhwen
    DiCioccio, A. Thomas
    Geba, Gregory P.
    Stahl, Neil
    Lipsich, Leah
    Braunstein, Ned
    Herman, Gary A.
    Yancopoulos, George D.
    Weinreich, David M.
    JOURNAL OF INFECTIOUS DISEASES, 2022, 227 (01) : 23 - 34
  • [8] Effectiveness of Subcutaneous Casirivimab and Imdevimab in Ambulatory Patients with COVID-19
    Jessica J. Jalbert
    Mohamed Hussein
    Vera Mastey
    Robert J. Sanchez
    Degang Wang
    Dana Murdock
    Laura Fariñas
    Jonathan Bussey
    Carlos Duart
    Boaz Hirshberg
    David M. Weinreich
    Wenhui Wei
    Infectious Diseases and Therapy, 2022, 11 : 2125 - 2139
  • [9] Treatment of COVID-19 with monoclonal antibodies casirivimab and imdevimab in pregnancy
    Rebecca Folkman
    Ola Blennow
    Tuulikki Tovatt
    Karin Pettersson
    Piotr Nowak
    Infection, 2023, 51 : 261 - 263
  • [10] Outcomes in Patients with Mild COVID-19 Treated With Casirivimab and Imdevimab or Bamlanivimab-A Single-Center Retrospective Cohort Study in the Bronx
    Balasubramanian, Prasanth
    Berto, Cesar Gabriel
    Hassan, Elaine
    Valentine, Nancy
    De Vos, Gabriele
    Coyle, Christina
    Sydney, Elana
    INFECTIOUS DISEASES IN CLINICAL PRACTICE, 2022, 30 (03)
12345